Using three machine-learning algorithms, we identified four hub genes-SRC, AURKA, PLK1, and CDC25-which exhibited high expression in tumor tissues and area under the receiver operating characteristic curve (AUC) values exceeding 0.8, suggesting their potential as therapeutic targets and prognostic markers for TNBC. Here, PLK1 is linked to neoplasm.